Amelia K. Fotheringham

Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice

Linda A. Gallo, Micheal Ward, Amelia K. Fotheringham et al. · Scientific Reports · 2016 · 142 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes

Micheal Ward, Nicole Flemming, Linda A. Gallo et al. · Scientific Reports · 2017 · 45 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

Rapid genome wide mapping of phosphine resistance loci by a simple regional averaging analysis in the red flour beetle, Tribolium castaneum

Rajeswaran Jagadeesan, Amelia K. Fotheringham, Paul R. Ebert et al. · BMC Genomics · 2013 · 38 citations · Full text

Life Sciences, Biology, Genetics +17

Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes

Greg H. Tesch, Karly C. Sourris, Shaun A. Summers et al. · Diabetologia · 2014 · 29 citations · Full text

Medicine, Endocrinology, Physiology +11

Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitis

Haressh Sajiir, Sahar Keshvari, Kuan Yau Wong et al. · Nature Communications · 2024 · 28 citations · Full text

Medicine, Immunology, Pharmacology +15